ABBV Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of June 6, 2022 Deadline in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
LAWSUITS FILED AGAINST MP, CRNC and AUPH - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS Pharmaceutical Investing
SHAREHOLDER ALERT: AI GRAB ABBV: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
Abbott Strengthens Its Connected Care Technologies with Latest NeuroSphere myPath Digital Health App Pharmaceutical Investing
KCSA Psychedelics Virtual Investor Conference Agenda Announced for April 27th & 28th Pharmaceutical Investing
Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance Pharmaceutical Investing
Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 at the American Society of Cataract and Refractive Surgery Annual Meeting Pharmaceutical Investing
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Adjuvant Monotherapy After Surgery for Locally Advanced, or High-Risk Early-Stage Triple-Negative Breast Cancer Life Science Investing
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Aurinia Pharmaceuticals Inc. Investors of a Lead Plaintiff Deadline of June 14, 2022 Pharmaceutical Investing
Several New Studies Presented at ECCMIC 2022 Confirm Veklury® Activity in Treating COVID-19 Pharmaceutical Investing
INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Aurinia Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - AUPH Pharmaceutical Investing
ABBV SHAREHOLDER ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
